CoChat

A Clinical Trial of Proton Pump Inhibitors to Treat Children with Chronic Otitis Media with Effusion

Open access
Dewan, Karuna, Lieu, Judith · 2019 · The Journal of International Advanced Otology

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; none of the 13 sources its claims cite is checked for support yet.

Abstract

Abstract OBJECTIVE: Gastroesophageal reflux (GER) is considered a cause of otitis media with effusion (OME). This study aimed to investigate whether OME can be effectively treated with a proton pump inhibitor (PPI), therefore implicating GER as a causative factor of OME. MATERIALS and METHODS: A PPI or placebo was randomly administered to enrolled subjects for 4–8 weeks. To monitor effusion status, subjects underwent monthly pneumatic otoscopy and acoustic reflectometry. At enrollment and at completion of treatment, subjects underwent an audiogram and tympanogram for assessing changes in hearing due to altered fluid levels in the middle ear. After the treatment period, tympanostomy tube placement was recommended for subjects with unresolved effusion. RESULTS: This study enrolled 16 patients with an average age of 5.17 years. Between the treatment and placebo groups, there was no significant difference in the need for tympanostomy tubes. At completion of this study, patients receiving Lansoprazole demonstrated a significant improvement in pure tone average (p

Overview

CoChat Summary

TL;DR

In a randomized double-blind placebo-controlled trial of 16 children with chronic otitis media with effusion (OME), lansoprazole did not significantly reduce the need for tympanostomy tubes compared with placebo, although lansoprazole-treated patients showed significant improvement in some audiologic measures. Recruitment difficulties and small sample size prevented definitive conclusions about proton pump inhibitor (PPI) efficacy.

Key findings

  • There was no significant difference between the lansoprazole and placebo groups in the need for tympanostomy tubes; the abstract reports 8 patients (50%) from the cohort required tube placement, while the Results report 8 (66%) of the 12 patients who completed the study required tubes.
  • At completion, patients receiving lansoprazole demonstrated significant improvement in pure tone average (p<0.01) and speech recognition thresholds (p=0.04); Table 3 shows significant p-values for left pure tone average (p=0.00) and left speech recognition threshold (p=0.04).
  • A total of 33% of subjects achieved resolution of effusion by the end of the 3-month study period, which the authors compare with a 28% spontaneous resolution rate reported by Rosenfeld et al., suggesting treatment with placebo or lansoprazole made no significant difference in disease course.
  • Lansoprazole was associated with significant reduction in diarrhea (p=0.03) and halitosis (p=0.03).

Methods

  • Randomized, double-blind, placebo-controlled study at a tertiary-care pediatric otolaryngology practice; children aged 2–12 years with chronic OME and indications for tympanostomy tube placement were enrolled, with exclusions for conditions increasing otitis media/OME/GER risk (e.g., cleft palate, neurologic delay, Down syndrome) and tympanic membrane structural abnormalities.
  • The treatment arm received lansoprazole for 4–8 weeks (15 mg/day if <30 kg; 30 mg/day if >30 kg), with monthly otologic examination and pneumatic otoscopy/acoustic reflectometry per the abstract; audiogram and tympanometry were performed at enrollment and study completion. The primary outcome aimed to double the resolution rate from 20% to 40% in 3 months with PPI.
  • Statistical analysis used SPSS version 21 and Microsoft Excel; two-sided binomial test for effusion/hearing loss, Fisher’s exact or chi-square for discrete variables, and Student’s t-test for continuous variables. The study enrolled 16 patients (10 males, 62.5%; mean age 5.17 years, SD 1.72); 14 had middle ear effusion and 14 had at least one type B tympanogram at enrollment.

Limitations

  • Stated: the authors report that difficulties with recruitment and small sample size meant the study was unable to demonstrate use of PPI in treating OME, and that a larger study is needed; they also note the tertiary-care setting made recruitment of patients without other comorbidities difficult, and they cannot determine whether audiologic improvement was due to PPI or natural healing.
  • Stated: the study aimed to recruit a minimum of 64 subjects but enrolled only 16 and was closed after 2 years due to inability to recruit; 4 patients (25%) dropped out, and only 12 completed.
  • Evident from the text: there are baseline imbalances between arms (placebo group had significantly more second-hand smoke exposure, p=0.02, and more pets at home, p=0.04; at completion, placebo had greater streptococcal infection history, p=0.03, second-hand smoke exposure, p=0.01, and weekly otalgia, p=0.01), and the paper contains contradictory statements about dropout group assignment—the abstract and Results say all withdrawals were in the lansoprazole group, while the Discussion says all were in the placebo group.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.5152/iao.2018.4286

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 11 Not checked · 40 Own results and interpretations

24 more claims

Create a free account to see all 51 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 6

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 21 references

Cited by

See all 10

Metadata

Authors
Dewan, K., & Lieu, J.
Affiliations
  • Stanford Medicine (US)
  • Washington University in St. Louis (US)
Venue
The Journal of International Advanced Otology
Publisher
Caleo
Published
2019-09-03
Volume
14
Issue
2
Pages
245-249
ISSN
  • 1308-7649 (ISSN-L)
  • 2148-3817
OpenAlex
W2883520120
Cited by
10
References
21
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2021: 2 · 2020: 2
FWCI
0.83
Type
journal article
Language
en
Open access
Locations
  • The Journal of International Advanced Otology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Otorhinolaryngology › Ear Surgery and Otitis Media
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
chronic otitis media with effusion, proton pump inhibitors, gastroesophageal reflux, lansoprazole, children, tympanostomy tubes, middle ear effusion, hearing outcomes, speech recognition threshold
MeSH terms
Acoustic Impedance Tests, Administration, Oral, Audiometry, Audiometry, Pure-Tone, Child, Child, Preschool, Chronic Disease, Double-Blind Method, Ear, Middle, Exudates and Transudates, Female, Gastroesophageal Reflux, Humans, Male, Middle Ear Ventilation, Otitis Media with Effusion, Placebos, Reflex, Acoustic, Otoscopy, Proton Pump Inhibitors, Lansoprazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.